No. |
Variant name |
Chromosome position |
Chromatin state |
Related regulatory elements |
Target genes |
Extended variants |
Associated traits |
1 |
rs7668293 |
chr4:150998079-150998080 |
Weak transcription Enhancers
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
2 |
rs564419020 |
chr4:150998089-150998090 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
3 |
rs181716199 |
chr4:150998159-150998160 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
4 |
rs148988934 |
chr4:150998190-150998191 |
Weak transcription Enhancers
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
5 |
rs143804642 |
chr4:150998218-150998219 |
Weak transcription Enhancers
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
6 |
rs185849039 |
chr4:150998241-150998242 |
Weak transcription Enhancers
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
7 |
rs562123258 |
chr4:150998288-150998289 |
Weak transcription Enhancers
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
8 |
rs566045775 |
chr4:150998314-150998315 |
Weak transcription Enhancers
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
9 |
rs534843495 |
chr4:150998341-150998342 |
Weak transcription Enhancers
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
10 |
rs548657377 |
chr4:150998349-150998350 |
Weak transcription Enhancers
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
11 |
rs531823880 |
chr4:150998409-150998410 |
Bivalent Enhancer Weak transcription Active TSS Flanking Active TSS Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
12 |
rs568310804 |
chr4:150998410-150998411 |
Bivalent Enhancer Weak transcription Active TSS Flanking Active TSS Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
13 |
rs34144863 |
chr4:150998464-150998465 |
Bivalent Enhancer Weak transcription Active TSS Flanking Active TSS Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
14 |
rs537246598 |
chr4:150998468-150998469 |
Bivalent Enhancer Weak transcription Active TSS Flanking Active TSS Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
15 |
rs557152981 |
chr4:150998471-150998472 |
Bivalent Enhancer Weak transcription Active TSS Flanking Active TSS Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
16 |
rs200712204 |
chr4:150998472-150998473 |
Bivalent Enhancer Weak transcription Active TSS Flanking Active TSS Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
17 |
rs577227901 |
chr4:150998476-150998477 |
Bivalent Enhancer Weak transcription Active TSS Flanking Active TSS Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
18 |
rs539696332 |
chr4:150998488-150998489 |
Bivalent Enhancer Weak transcription Active TSS Flanking Active TSS Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
19 |
rs148171953 |
chr4:150998508-150998509 |
Bivalent Enhancer Weak transcription Active TSS Flanking Active TSS Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
20 |
rs572786747 |
chr4:150998524-150998525 |
Bivalent Enhancer Weak transcription Active TSS Flanking Active TSS Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
21 |
rs10003178 |
chr4:150998544-150998545 |
Bivalent Enhancer Weak transcription Active TSS Flanking Active TSS Enhancers
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
mRNA abundance
|
22 |
rs561448326 |
chr4:150998554-150998555 |
Bivalent Enhancer Weak transcription Active TSS Flanking Active TSS Enhancers
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
23 |
rs141127848 |
chr4:150998564-150998565 |
Bivalent Enhancer Weak transcription Active TSS Flanking Active TSS Enhancers
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
24 |
rs565902666 |
chr4:150998608-150998609 |
Bivalent Enhancer Weak transcription Active TSS Flanking Active TSS Bivalent/Poised TSS Enhancers
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
25 |
rs79202291 |
chr4:150998635-150998636 |
Bivalent Enhancer Weak transcription Active TSS Flanking Active TSS Bivalent/Poised TSS Enhancers
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
26 |
rs543621912 |
chr4:150998644-150998645 |
Bivalent Enhancer Weak transcription Active TSS Flanking Active TSS Bivalent/Poised TSS Enhancers
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
27 |
rs563509011 |
chr4:150998671-150998672 |
Bivalent Enhancer Weak transcription Active TSS Flanking Active TSS Bivalent/Poised TSS Enhancers
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
28 |
rs111996967 |
chr4:150998674-150998675 |
Bivalent Enhancer Weak transcription Active TSS Flanking Active TSS Bivalent/Poised TSS Enhancers
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
29 |
rs533336487 |
chr4:150998733-150998734 |
Bivalent Enhancer Weak transcription Active TSS Flanking Active TSS Bivalent/Poised TSS Enhancers
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
30 |
rs79788742 |
chr4:150998760-150998761 |
Bivalent Enhancer Weak transcription Active TSS Flanking Active TSS Bivalent/Poised TSS Enhancers
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
31 |
rs372157848 |
chr4:150998870-150998871 |
Bivalent/Poised TSS Flanking Bivalent TSS/Enh Weak transcription Active TSS Flanking Active TSS Enhancers Bivalent Enhancer
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
32 |
rs552820907 |
chr4:150998878-150998879 |
Bivalent/Poised TSS Flanking Bivalent TSS/Enh Weak transcription Active TSS Flanking Active TSS Enhancers Bivalent Enhancer
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
33 |
rs150719061 |
chr4:150998898-150998899 |
Bivalent/Poised TSS Flanking Bivalent TSS/Enh Weak transcription Active TSS Flanking Active TSS Enhancers Bivalent Enhancer
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
34 |
rs528485065 |
chr4:150998910-150998911 |
Bivalent/Poised TSS Flanking Bivalent TSS/Enh Weak transcription Active TSS Flanking Active TSS Enhancers Bivalent Enhancer
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
35 |
rs72730319 |
chr4:150998937-150998938 |
Bivalent/Poised TSS Flanking Bivalent TSS/Enh Weak transcription Active TSS Flanking Active TSS Enhancers Bivalent Enhancer
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
36 |
rs568577431 |
chr4:150999029-150999030 |
Bivalent/Poised TSS Active TSS Flanking Active TSS Flanking Bivalent TSS/Enh Enhancers Bivalent Enhancer
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
37 |
rs199544269 |
chr4:150999035-150999036 |
Bivalent/Poised TSS Active TSS Flanking Active TSS Flanking Bivalent TSS/Enh Enhancers Bivalent Enhancer
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
38 |
rs550817125 |
chr4:150999047-150999048 |
Bivalent/Poised TSS Active TSS Flanking Active TSS Flanking Bivalent TSS/Enh Enhancers Bivalent Enhancer
|
TF binding regionCpG island
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
39 |
rs76774998 |
chr4:150999062-150999063 |
Bivalent/Poised TSS Active TSS Flanking Active TSS Flanking Bivalent TSS/Enh Enhancers Bivalent Enhancer
|
TF binding regionCpG island
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
40 |
rs539390704 |
chr4:150999066-150999067 |
Bivalent/Poised TSS Active TSS Flanking Active TSS Flanking Bivalent TSS/Enh Enhancers Bivalent Enhancer
|
TF binding regionCpG island
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
41 |
rs374492582 |
chr4:150999100-150999101 |
Bivalent/Poised TSS Active TSS Flanking Active TSS Flanking Bivalent TSS/Enh Enhancers Bivalent Enhancer
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
42 |
rs10005992 |
chr4:150999112-150999113 |
Bivalent/Poised TSS Active TSS Flanking Active TSS Flanking Bivalent TSS/Enh Enhancers Bivalent Enhancer
|
TF binding region
|
1 gene(s)
|
LD-proxies of rSNPOverlapped rCNV
|
mRNA abundance
|
43 |
rs573006374 |
chr4:150999145-150999146 |
Bivalent/Poised TSS Active TSS Flanking Active TSS Flanking Bivalent TSS/Enh Enhancers Bivalent Enhancer
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
44 |
rs10028598 |
chr4:150999167-150999168 |
Bivalent/Poised TSS Active TSS Flanking Active TSS Flanking Bivalent TSS/Enh Enhancers Bivalent Enhancer
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
45 |
rs535438558 |
chr4:150999187-150999188 |
Bivalent/Poised TSS Active TSS Flanking Active TSS Flanking Bivalent TSS/Enh Enhancers Bivalent Enhancer
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
46 |
rs112573840 |
chr4:150999217-150999218 |
Bivalent/Poised TSS Active TSS Flanking Active TSS Enhancers Bivalent Enhancer Flanking Bivalent TSS/Enh
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
47 |
rs376837887 |
chr4:150999218-150999219 |
Bivalent/Poised TSS Active TSS Flanking Active TSS Enhancers Bivalent Enhancer Flanking Bivalent TSS/Enh
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
48 |
rs575015426 |
chr4:150999258-150999259 |
Bivalent/Poised TSS Active TSS Flanking Active TSS Enhancers Bivalent Enhancer Flanking Bivalent TSS/Enh
|
TF binding regionCpG island
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
49 |
rs543880212 |
chr4:150999264-150999265 |
Bivalent/Poised TSS Active TSS Flanking Active TSS Enhancers Bivalent Enhancer Flanking Bivalent TSS/Enh
|
TF binding regionCpG island
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
50 |
rs563576595 |
chr4:150999285-150999286 |
Bivalent/Poised TSS Active TSS Flanking Active TSS Enhancers Bivalent Enhancer Flanking Bivalent TSS/Enh
|
TF binding regionCpG island
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|